Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Associations between COVID-19 infection, tobacco smoking and nicotine use, common respiratory conditions and inhaled corticosteroids: a prospective QResearch-Case Mix Programme data linkage study January-May 2020

Nicola Lindson, Min Gao, Jamie Hartmann-Boyce, Margaret Smith, View ORCID ProfilePaul Aveyard, Duncan Young, Carol Coupland, Pui San Tan, Ashley K. Clift, David Harrison, Doug Gould, Ian D Pavord, Peter Watkinson, Julia Hippisley-Cox
doi: https://doi.org/10.1101/2020.06.05.20116624
Nicola Lindson
1University of Oxford, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, Oxford, UK, OX2 6GG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Min Gao
1University of Oxford, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, Oxford, UK, OX2 6GG
2NIHR Oxford Biomedical Research Centre, Oxford University Hospitals, NHS Foundation Trust, Oxford, UK, OX2 6GG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jamie Hartmann-Boyce
1University of Oxford, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, Oxford, UK, OX2 6GG
2NIHR Oxford Biomedical Research Centre, Oxford University Hospitals, NHS Foundation Trust, Oxford, UK, OX2 6GG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margaret Smith
1University of Oxford, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, Oxford, UK, OX2 6GG
2NIHR Oxford Biomedical Research Centre, Oxford University Hospitals, NHS Foundation Trust, Oxford, UK, OX2 6GG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paul Aveyard
1University of Oxford, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, Oxford, UK, OX2 6GG
2NIHR Oxford Biomedical Research Centre, Oxford University Hospitals, NHS Foundation Trust, Oxford, UK, OX2 6GG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul Aveyard
  • For correspondence: paul.aveyard@phc.ox.ac.uk
Duncan Young
3University of Oxford, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK, OX3 9DU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carol Coupland
4University of Nottingham, Faculty of Medicine & Health Sciences, University Park, Nottingham, UK, NG7 2RD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pui San Tan
1University of Oxford, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, Oxford, UK, OX2 6GG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ashley K. Clift
1University of Oxford, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, Oxford, UK, OX2 6GG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Harrison
5Intensive Care National Audit & Research Centre (icnarc), Napier House, 24 High Holborn, London, UK, WC1V 6AZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Doug Gould
5Intensive Care National Audit & Research Centre (icnarc), Napier House, 24 High Holborn, London, UK, WC1V 6AZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ian D Pavord
6University of Oxford, Nuffield Department of Medicine, Old Road Campus, Oxford, UK, OX3 7FZ
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Watkinson
3University of Oxford, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK, OX3 9DU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julia Hippisley-Cox
1University of Oxford, Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, Oxford, UK, OX2 6GG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction Epidemiological and laboratory research seems to suggest that smoking and perhaps nicotine alone could reduce the severity of COVID-19. Likewise, there is some evidence that inhaled corticosteroids could also reduce its severity, opening the possibility that nicotine and inhaled steroids could be used as treatments.

Methods In this prospective cohort study, we will link English general practice records from the QResearch database to Public Health England’s database of SARS-CoV-2 positive tests, Hospital Episode Statistics, admission to intensive care units, and death from COVID-19 to identify our outcomes: hospitalisation, ICU admission, and death due to COVID. Using Cox regression, we will perform sequential adjustment for potential confounders identified by separate directed acyclic graphs to:

  1. Assess the association between smoking and COVID-19 disease severity, and how that changes on adjustment for smoking-related comorbidity.

  2. More closely characterise the association between smoking and severe COVID-19 disease by assessing whether the association is modified by age (as a proxy of length of smoking), gender, ethnic group, and whether people have asthma or COPD.

  3. Assess for evidence of a dose-response relation between smoking intensity and disease severity, which would help create a case for causality.

  4. Examine the association between former smokers who are using NRT or are vaping and disease severity.

  5. Examine whether pre-existing respiratory disease is associated with severe COVID-19 infection.

  6. Assess whether the association between chronic obstructive pulmonary disease (COPD) and asthma and COVID-19 disease severity is modified by age, gender, ethnicity, and smoking status.

  7. Assess whether the use of inhaled corticosteroids is associated with severity of COVID-19 disease.

  8. To assess whether the association between use of inhaled corticosteroids and severity of COVID-19 disease is modified by the number of other airways medications used (as a proxy for severity of condition) and whether people have asthma or COPD.

Conclusions This representative population sample will, to our knowledge, present the first comprehensive examination of the association between smoking, nicotine use without smoking, respiratory disease, and severity of COVID-19. We will undertake several sensitivity analyses to examine the potential for bias in these associations.

Competing Interest Statement

All authors have completed the ICMJE uniform disclosure form and declare: no support from any organisation for the submitted work; Dr. Tan reports personal fees from AstraZeneca, personal fees from Duke-NUS, outside the submitted work; Dr. Gould reports grants from Wellcome Trust, during the conduct of the study; Dr. Pavord reports personal fees from AstraZeneca, personal fees from Boehringer Ingelheim, personal fees from Aerocrine, personal fees from Almirall, personal fees from Novartis, personal fees from GlaxoSmithKline, personal fees from Genentech, personal fees from Regeneron, personal fees from Teva, grants and personal fees from Chiesi, grants and personal fees from Sanofi, personal fees from Circassia, personal fees from Knopp, grants from NIHR, outside the submitted work; Dr. Watkinson reports grants from Wellcome, grants from NIHR Biomedical Research Centre, Oxford, grants from University of Oxford Medical Sciences Division, during the conduct of the study; personal fees from Sensyne Health, grants from Sensyne Health, outside the submitted work; Dr. Hippisley-Cox reports grants from National Institute for Health Research Biomedical Research Centre, Oxford, grants from John Fell Oxford University Press Research Fund, grants from Cancer Research UK (CR-UK) grant number C5255/A18085, through the Cancer Research UK Oxford Centre, grants from the Oxford Wellcome Institutional Strategic Support Fund (204826/Z/16/Z), during the conduct of the study; personal fees and other from ClinRisk Ltd, outside the submitted work; and JHC is an unpaid director of QResearch, a not-for-profit organisation which is a partnership between the University of Oxford and EMIS Health who supply the QResearch database used for this work; no other relationships or activities that could appear to have influenced the submitted work.

Funding Statement

PA is an NIHR senior investigators and is funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC) Obesity, Diet and Lifestyle Theme and National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care Oxford. MG, JH-B, MS are funded by Oxford Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

QResearch committee are evaluating this.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Not applicable

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted June 08, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Associations between COVID-19 infection, tobacco smoking and nicotine use, common respiratory conditions and inhaled corticosteroids: a prospective QResearch-Case Mix Programme data linkage study January-May 2020
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Associations between COVID-19 infection, tobacco smoking and nicotine use, common respiratory conditions and inhaled corticosteroids: a prospective QResearch-Case Mix Programme data linkage study January-May 2020
Nicola Lindson, Min Gao, Jamie Hartmann-Boyce, Margaret Smith, Paul Aveyard, Duncan Young, Carol Coupland, Pui San Tan, Ashley K. Clift, David Harrison, Doug Gould, Ian D Pavord, Peter Watkinson, Julia Hippisley-Cox
medRxiv 2020.06.05.20116624; doi: https://doi.org/10.1101/2020.06.05.20116624
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Associations between COVID-19 infection, tobacco smoking and nicotine use, common respiratory conditions and inhaled corticosteroids: a prospective QResearch-Case Mix Programme data linkage study January-May 2020
Nicola Lindson, Min Gao, Jamie Hartmann-Boyce, Margaret Smith, Paul Aveyard, Duncan Young, Carol Coupland, Pui San Tan, Ashley K. Clift, David Harrison, Doug Gould, Ian D Pavord, Peter Watkinson, Julia Hippisley-Cox
medRxiv 2020.06.05.20116624; doi: https://doi.org/10.1101/2020.06.05.20116624

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Respiratory Medicine
Subject Areas
All Articles
  • Addiction Medicine (230)
  • Allergy and Immunology (507)
  • Anesthesia (111)
  • Cardiovascular Medicine (1258)
  • Dentistry and Oral Medicine (207)
  • Dermatology (148)
  • Emergency Medicine (283)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (538)
  • Epidemiology (10048)
  • Forensic Medicine (5)
  • Gastroenterology (502)
  • Genetic and Genomic Medicine (2482)
  • Geriatric Medicine (239)
  • Health Economics (482)
  • Health Informatics (1653)
  • Health Policy (757)
  • Health Systems and Quality Improvement (638)
  • Hematology (250)
  • HIV/AIDS (536)
  • Infectious Diseases (except HIV/AIDS) (11889)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (255)
  • Medical Ethics (75)
  • Nephrology (269)
  • Neurology (2301)
  • Nursing (140)
  • Nutrition (354)
  • Obstetrics and Gynecology (458)
  • Occupational and Environmental Health (537)
  • Oncology (1258)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (326)
  • Pediatrics (737)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2294)
  • Public and Global Health (4850)
  • Radiology and Imaging (846)
  • Rehabilitation Medicine and Physical Therapy (493)
  • Respiratory Medicine (654)
  • Rheumatology (288)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (228)
  • Surgery (273)
  • Toxicology (44)
  • Transplantation (130)
  • Urology (100)